![]() |
|
Names | |
---|---|
IUPAC name
(Z)-7-[(2R,3S,4S)-4-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-6-oxo-tetrahydropyran-3-yl]hept-5-enoic acid
|
|
Other names
11-Dehydro-thromboxane B2
|
|
Identifiers | |
3D model (JSmol)
|
|
ChEBI | |
ChemSpider | |
KEGG | |
PubChem CID
|
|
|
|
|
|
Properties | |
C20H32O6 | |
Molar mass | 368.46 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
![]() ![]() ![]() |
|
Infobox references | |
11-Dehydrothromboxane B2 (or 11-dehydro-TXB2) is produced from the breakdown of thromboxane A2. It is released by activated platelets and urine levels of 11-dehydro-TXB2 can be used to monitor the response to aspirin therapy when used to prevent heart disease and in diseases where platelet activation is prominent.